275 related articles for article (PubMed ID: 31210353)
21. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP
J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL
FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
[TBL] [Abstract][Full Text] [Related]
23. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
24. Reduced hsa-miR-124-3p levels are associated with the poor survival of patients with hepatocellular carcinoma.
Long HD; Ma YS; Yang HQ; Xue SB; Liu JB; Yu F; Lv ZW; Li JY; Xie RT; Chang ZY; Lu GX; Xie WT; Fu D; Pang LJ
Mol Biol Rep; 2018 Dec; 45(6):2615-2623. PubMed ID: 30341691
[TBL] [Abstract][Full Text] [Related]
25. Prognostic values of microRNA-130 family expression in patients with cancer: a meta-analysis and database test.
Peng Z; Duan F; Yin J; Feng Y; Yang Z; Shang J
J Transl Med; 2019 Oct; 17(1):347. PubMed ID: 31640738
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.
Wang G; Dong F; Xu Z; Sharma S; Hu X; Chen D; Zhang L; Zhang J; Dong Q
BMC Cancer; 2017 Dec; 17(1):805. PubMed ID: 29191172
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma.
Xue X; Zhao Y; Wang X; Qin L; Hu R
J Cell Biochem; 2019 Jan; 120(1):135-142. PubMed ID: 30238497
[TBL] [Abstract][Full Text] [Related]
29. Prognostic microRNA signature for estimating survival in patients with hepatocellular carcinoma.
Yerukala Sathipati S; Aimalla N; Tsai MJ; Carter T; Jeong S; Wen Z; Shukla SK; Sharma R; Ho SY
Carcinogenesis; 2023 Dec; 44(8-9):650-661. PubMed ID: 37701974
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma.
Gu H; Guo X; Zou L; Zhu H; Zhang J
Mol Cell Biochem; 2013 Mar; 375(1-2):23-30. PubMed ID: 23291979
[TBL] [Abstract][Full Text] [Related]
31. miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients.
Huang CY; Huang XP; Zhu JY; Chen ZG; Li XJ; Zhang XH; Huang S; He JB; Lian F; Zhao YN; Wu GB
Oncol Rep; 2015 Jun; 33(6):2889-98. PubMed ID: 25962360
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of miR-342-3p in hepatocellular carcinoma tissues and its prognostic significance.
Gao Y; Zhang SG; Wang ZH; Liao JC
Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2098-2102. PubMed ID: 28537676
[TBL] [Abstract][Full Text] [Related]
33. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
34. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
36. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.
Chen M; Hu W; Xiong CL; Qu Z; Yin CQ; Wang YH; Luo CL; Guan Q; Yuan CH; Wang FB
Oncotarget; 2016 Dec; 7(49):80751-80764. PubMed ID: 27811373
[TBL] [Abstract][Full Text] [Related]
37. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Chen L; Chu F; Cao Y; Shao J; Wang F
Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
[TBL] [Abstract][Full Text] [Related]
38. High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.
Wang WY; Zhang HF; Wang L; Ma YP; Gao F; Zhang SJ; Wang LC
Diagn Pathol; 2014 Aug; 9():160. PubMed ID: 25123453
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and prognostic significance of serum miR-24-3p in HBV-related hepatocellular carcinoma.
Meng FL; Wang W; Jia WD
Med Oncol; 2014 Sep; 31(9):177. PubMed ID: 25129312
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of miR-1180-3p in hepatocellular carcinoma: a study based on bioinformatics analysis and RT-qPCR validation.
Zhou Z; Zhou X; Jiang Y; Qiu M; Liang X; Lin Q; Guo Q; Nong C; Huo R; Chen Q; Liu H; Liu Y; Zhu S; Wang M; Yu H
Sci Rep; 2020 Jul; 10(1):11573. PubMed ID: 32665670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]